Abstract
Data on the distribution of HBV-DNA and other serological markers of hepatitis B virus infection in a population of asymptomatic carriers in Ethiopia are reported. As compared to data from other countries of similar or lower levels of endemicity, it has been found that HBV-DNA prevalence and its correlation with HBeAg/anti-HBe status is similar to that of northern Europe. HBV-DNA is present in 84% of HBe Ag-positive sera but in only 4% of anti-HBe-positive sera, where the lowest concentration of DNA (less than 5 pgr/20 µl) was found.
The trend of increasing prevalence of serological markers with age seems to indicate a considerable horizontal transmission still present in this age range (18–30). In keeping with data of other authors a 3% of HBV-DNA positivity in anti HBc only positive sera was found.
No regional or ethnical differences of HBV-DNA positive sera across the country were observed. There is also no evidence of any correlation between HBV-DNA prevalence and HBsAg subtypes ad and ay.
Similar content being viewed by others
References
Aldershvile J., Skinhoj P., Frösner G.G., Black F., Deinhardt F., Hardt F. and Nielsen J.O. (1980): The expression pattern of hepatitis Be Antigen and Antibody in different ethnic and clinical groups of hepatitis B surface Antigen carriers. — The Journal of Infectious disease 142: 18–22.
Beasley R.P., Hwang L.Y., Lin C.C. and Chien C.S. (1981): Hepatocellular carcinoma and Hepatitis B virus: A prospective study of 22,707 men in Taiwan. —Lancet 2: 1129–1133.
Beasley R.P. (1982): Hepatitis B virus as the etiologic agent in Hepatocellular carcinoma: epidemiological considerations. — Hepatology 2: 215–265.
Bonino F., Rosina F., Rizzetto M. et al. (1986): Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. — Gastroenterology 90: 1268–1273.
Brechot C., Degos F., Lugassy C., Thiers V., Zafrani D.F.S., Bismuth H., Trepo C., Benhamon J.P., Wands J., Isselbacher K., Tiollais P. and Berthelot P. (1985): Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. — The New England Journ. of Med. 31: 270–276.
Chung W.K. Sun H.S., Park D.H., Minux G.Y. and Hoofnagle J.H. (1983): Primary hepatocellular carcinoma and hepatitis B virus infection in Korea. —Journal of Medical Virology 11: 99–104.
C-Ming Chu, Karayiannis P., Fowler M.J.F., Monjardino J., Yun-Fan L. and Thomas H.C. (1985): Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus in serum. —Hepatology 5: 431–434.
Cummings I.W., Browne J.K., Salser W.A., Tyler G.V., Snyder R.L., Smolec J.M. and Summers J. (1980): Isolation, characterization and comparison of recombinant DNAs derived from genomes of human Hepatitis B virus and woodchuck Hepatitis virus. —Proc. Natl. Acad. Sci. USA 77: 1842–1846.
Ding-Shim C., Ming-Yang L., Sheng-Sheng L., Pei Ming Y., Tin-Chunn S. and Juci-Low S. (1986): Serum HBsAg, HBsAg, anti-HBe and HBV-DNA in asymptomatic carriers in Taiwan. — Journal of Medical Virology 19: 87–94.
Hadziyannis S., Lieberman H.M., Karvountris G.G. and Shafritz D.A. (1983): Analysis of liver disease, nuclear HbcAg, viral replication and hepatitis B virus DNA in liver and serum of HBsAg VS Anti-HBe positive carriers of hepatitis B virus. — Hepatology 3: 656–662.
Hailu K., Rapicetta M., Rossi G.B., Bisanti L., Bekura D., Morace G., Palladino P., DiRienzo A.M., Conti S., Bassani F., Bertolaso G. and Pasquini P. (1988): Ethiopian national hepatitis B study. — Journal of Medical Virology 24: 75–83.
Harrison T.J., Bal V., Wheeler E.G., Meacock T.J., Harrison J.F. and Zuckerman A.J. (1985): Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen. — British Medical Journal 290: 663–664.
Hu M., Scheuzle D., Deinhardt F. and Soheid R. (1984): Epidemiology of hepatitis A and B in the Shangai area: prevalence of serum markers. — American Journal of Epidemiology 120: 404–413.
Karayiannis P., Fowler M.J.F., Lok A.S.F., Greenfield C., Monjardino J. and Thomas H.C. (1985): Detection of serum HBV-DNA by molecular hybridization: correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. —Journal of Hepatology 1: 99–106.
Kashiwagi S., Hayashi J., Nomura H., Kajiyama W., Ikematsu H., Shingu T., Hayashida K. and Koji M. (1986): Age-specific prevalence of hepatitis Be antigen (HBeAg) and antibody to HBeAg (anti-HBe) among asymptomatic hepatitis B surface antigen (HBsAg) carriers in Okinawa ad Kyushu, Japan. —Microbiol. Immunol. 30: 675–682.
Matsuyama Y., Omata M., Yokosuka O., Imazeki F., Ioshimi I. and Okuda K. (1985): Discordance of hepatitis Be Antigen/Antibody and hepatitis B virus DNA in serum. — Gastroenterology 89: 1104–1108.
Morace G., Von der Helm K., Jilg W. and Deinhardt F. (1985): Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay. — Journal of Virological Meth. 12: 235–242.
Scotto J., Hadchouel M., Hery C., Yvant J., Tiollais P. and Brechot C. (1983): Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. — Hepatology 3: 279–283.
Thomas H.C., Karayannis P., Fowler M.J.F. and Monjardino J. (1985): Clinical uses of HBV DNA assays. — J. Virol. Meth. 10: 291–294.
Van Ditshuijsen T.J.M., Selten G.C.M., VanLoon A.M., Wolters G., Matthyssen L. and Yap S.H. (1985): Detection of HBV-DNA in serum and relation with the IgM class anti-HBc titers in hepatitis B virus infection. — Journal of Medical Virology 15:49–56.
Waller D.K., Nixon P., Taluxdar S. and Al-Admawy A.M.O. (1984): A study of prevalence of E-antigen infectivity marker in the HBsAg positive hospital patients. — Sandi Medical Journal 5: 227–228.
Wands J.R., Frujita Y.K., Isselbacher K.J., Degott C., Schellekus H., Dazza M.C., Thiers V., Tiollais P. and Brechot C. (1986): Identification and transmission of hepatitis B virus-related variants. — Proc. Natl. Acad. Sci. USA 83: 6608–6612.
Yun-Fan L., Chia-Ming C., Deng Y.L., I-shyan S., Chaur-Young Y. and Miau-Ju-Huang (1984): Age-specific prevalence and significance of hepatitis Be Antigen and Antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. — Journal of Medical Virology 13: 385–391.
Zmuness W. (1981): Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. — Prog. Med. Virol. 27: 1–15.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rapicetta, M., Hailù, K., Morace, G. et al. Prevalence of HBeAg, anti-HBe serological markers and HBV-DNA in asymptomatic carriers in Ethiopia. Eur J Epidemiol 5, 481–485 (1989). https://doi.org/10.1007/BF00140145
Issue Date:
DOI: https://doi.org/10.1007/BF00140145